Skip to contentP
Petmed Express Inc
P
PETSPetmed Express Inc Q3 2026 · 10-Q
Revenue$40.66M$40.66M−21.7% vs Q3 2025 Net Income-$10.55M-$10.55MN/M vs Q3 2025 EPS Diluted-$0.50-$0.50N/M vs Q3 2025 Gross Profit$9,456,000−41.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petmed Express Inc · CIK 1040130 · Engraved from SEC EDGAR
Operating Cash Flowderived-$9,205,000N/M Free Cash Flowderived-$9,184,000N/M Margins · derivedGross margin23.3%−7.8 pt vs Q3 2025
Operating margin-25.7%−24.9 pt vs Q3 2025
Net margin-26.0%−24.6 pt vs Q3 2025
ended Dec 31, 2025 · filed Feb 5, 2026 · 36 d after period end